Ignite Creation Date:
2024-05-05 @ 10:38 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01151488
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2010-06-25
Brief Title:
Nutrition Exercise and Breast Cancer Survivorship
Sponsor:
Baltimore VA Medical Center
Organization:
Baltimore VA Medical Center
Study Overview
Official Title:
Impact of Nutrition and Exercise on Glucose Metabolism Inflammation and Body Composition in Older Breast Cancer Survivors
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to examine the effects of resistance training on the reasons mechanisms underlying the development of fatigue muscle weakness and wasting sarcopenia and impaired physical functioning poor balance and walking associated with breast cancer survivorship
Detailed Description:
Breast cancer is the most frequently diagnosed cancer in women representing 26 of all female cancers It is also the second leading cause of cancer related deaths in the US for women Side effects of the cancer and treatment therapies may result in inactivity and inadequate intakes of various nutrients including protein and vitamin D associated with cardiovascular disease CVD and type 2 diabetes High concentrations of systemic and local inflammation correlate well with CVD and diabetes risk There is substantial evidence to support that incorporating physical activity and nutrition into ones lifestyle can reduce inflammation and ultimately the progression to CVD and diabetes Understanding the role of exercise and diet management in the health of breast cancer survivors will allow us to translate these findings into therapy guidelines
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P30AG028747 | NIH | None | httpsreporternihgovquickSearchP30AG028747 |